Cargando…

SARS-CoV-2 Omicron Variant in Human Saliva Samples in Cell-Free Form

This cross-sectional study investigates cell-free viral loads in saliva samples from patients who have been infected with the Omicron variant of SARS-CoV-2.

Detalles Bibliográficos
Autores principales:	Imai, Kenichi, Ikeno, Ryo, Tanaka, Hajime, Takada, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857355/ https://www.ncbi.nlm.nih.gov/pubmed/36622677 http://dx.doi.org/10.1001/jamanetworkopen.2022.50207

Ejemplares similares

From Delta to Omicron SARS-CoV-2 variant: Switch to saliva sampling for higher detection rate
por: Cornette, Margot, et al.
Publicado: (2022)

Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant
por: Bordi, Licia, et al.
Publicado: (2023)

Omicron: A SARS‐CoV‐2 variant of real concern
por: Gattinger, Pia, et al.
Publicado: (2022)

Performance of nasopharyngeal swab and saliva in detecting Delta and Omicron SARS‐CoV‐2 variants
por: Uršič, Tina, et al.
Publicado: (2022)

Serial semiquantitative detection of SARS-CoV-2 in saliva samples
por: Mao, Ming-Hui, et al.
Publicado: (2021)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

SARS-CoV-2 Omicron detection by antigen tests using saliva
por: Murakami, Kaoru, et al.
Publicado: (2022)

Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
por: Taenaka, Ryutaro, et al.
Publicado: (2022)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

What Is New With Omicron Variant of SARS-CoV-2 in Children?
por: Bittmann, Stefan, et al.
Publicado: (2022)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variants in Bangladesh: Pandemic to endemic
por: Jubair, Mohammad, et al.
Publicado: (2023)

PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
por: Su, Jingyi, et al.
Publicado: (2022)

Omicron Wave SARS-CoV-2 Diagnosis: Evaluation of Saliva, Anterior Nasal, and Nasopharyngeal Swab Samples
por: Migueres, Marion, et al.
Publicado: (2022)

Saliva sampling for chasing SARS-CoV-2: A Game-changing strategy
por: Borghi, Elisa, et al.
Publicado: (2021)

Highly efficient respirators are needed for the Omicron variant of SARS-CoV-2
por: Mattiuzzi, C., et al.
Publicado: (2022)

Detecting SARS-CoV-2 Omicron B.1.1.529 Variant in Wastewater Samples by Using Nanopore Sequencing
por: Rasmussen, Lasse D., et al.
Publicado: (2022)

MIS-C Triggered by Omicron Variant of SARS-CoV-2
por: Balasubramanian, S., et al.
Publicado: (2022)

ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
por: Ou, Jianxia, et al.
Publicado: (2022)

Cognitive dysfunction of patients infected with SARS-CoV-2 omicron variant in Shanghai, China
por: Yuan, Ping, et al.
Publicado: (2023)

Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA
por: Seid, Arlene G., et al.
Publicado: (2022)

Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants
por: Mizoue, Tetsuya, et al.
Publicado: (2022)

Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva
por: Iwasaki, Sumio, et al.
Publicado: (2020)

Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern
por: Calvet, Guilherme, et al.
Publicado: (2023)

SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
por: Li, Pengfei, et al.
Publicado: (2022)

Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021
por: Kim, Eun-Young, et al.
Publicado: (2022)

Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab
por: Vellas, Camille, et al.
Publicado: (2022)

Experimental Infection of Mink with SARS-COV-2 Omicron Variant and Subsequent Clinical Disease
por: Virtanen, Jenni, et al.
Publicado: (2022)

Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain
por: Chin, Alex Wing Hong, et al.
Publicado: (2022)

“Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”
por: Vera-Lise, Ihm, et al.
Publicado: (2022)

Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients
por: Chimon, Alice, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters
por: Zhang, Ya-Nan, et al.
Publicado: (2022)

Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 – vigilance needed
por: Huang, Jing, et al.
Publicado: (2022)

Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
por: Tai, Wanbo, et al.
Publicado: (2022)

Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
por: Granerud, Beathe K., et al.
Publicado: (2022)

USEFULNESS OF SALIVA SAMPLES FOR DETECTING SARS-CoV-2 RNA AMONG LIVER DISEASE PATIENTS
por: Villar, Livia Melo, et al.
Publicado: (2021)

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
por: Luo, Deyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_21f7328a8j24cun6ic7j478gre